4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049452
Director sold 1,184 shares at $14.30 ($16,931)
- Director acquired 2,366 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…